Delivery Order SPE2DB22D2206-SPE2DB25FJD63
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg at a ceiling value of $1,089.84 under a firm fixed price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VIMPAT 200 MG tablets in a quantity of 60 units, with a contract ceiling value of $1,089.82. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract has an ultimate completion date of July 28, 2025, and AmerisourceBergen will perform this work from its corporate office location in...
- The Defense Logistics Agency awarded a $1,020.96 delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg on August 7, 2025, with a completion date of August 8, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. VIMPAT (lacosamide) is a prescription medication used in the treatment of partial-onset seizures and is being supplied to support federal medical procurement needs. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $971.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VIMPAT 10 MG/ML solution in 200ML bottles. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill requirements under the order. The order was awarded on August 16, 2023 with performance period concluding on August 17, 2023. No set aside designation or subcontractors were...
- The Defense Logistics Agency awarded a $1,455.99 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for VIMPAT 10 mg/mL Solution in 200 mL quantities. This firm fixed price order, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was awarded without a set-aside designation through competitive procurement, and performance will occur at the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 100 MG TABLET 60S for a total ceiling value of $1,484.97. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product called VIMPAT 10 MG/ML SOLUTION 200ML. The contract, valued at $1,292.15, has an ultimate completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 10 mg/ml solution in 200 ml containers, with a ceiling value of $1,105.15. It is a firm fixed-price delivery order contract with a period of performance ending on July 16, 2025. The contract is not set-aside for any specific business type. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,825.20 to Amerisourcebergen Drug Corporation for 4561661370 VIMPAT 10 MG/ML SOLUTION 200ML. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania, fulfilling the agency's requirements under the contract by August 2, 2023 after a start date of August 1. No major subcontractors or set aside designations were indicated. The Defense Logistics...
- The Defense Logistics Agency awarded a $422,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VIMPAT 10 MG/ML solution in 200ML bottles. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 17, 2023, in support of Department of Defense requirements. Amerisourcebergen will perform under this contract without a set-aside designation. No subcontractors or additional context were provided in the award details.
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD63Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml Solution 200ml, with a ceiling value of $1,136.96 under a firm fixed price contract type. The award was executed on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-set-aside competitive award is being performed at the contractor's facility in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is an anticonvulsant medication used in the treatment of neurological conditions, reflecting the Defense Logistics Agency's Medical Supply Chain procurement needs to support military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp has demonstrated capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, positioning it as a critical vendor for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/30/25 |